BioPh 2009 debuts in Madrid
Marking the 20th anniversary of the pharmaceutical ingredients industry’s
leading exhibition and networking event, CPhI 2009 will make an important
addition to its event family: Biosolutions for Pharma
BioPh, or Biosolutions for Pharma, is the fourth exhibition, Ms Cennydd continues: “The bio-pharma convergence trend is
seminar and partnering platform to be introduced under the CPhI ultimately about drug innovation routes and then cost and time-to-
Worldwide event umbrella. It will focus on the biotech sector’s market. BioPh will deliver great opportunities at this crossroad. After
increasing role in pharmaceutical innovation. the successful development of the ICSE contract services and P-MEC
The new event will be a natural magnet for companies and
equipment events, the launch of BioPh is a logical step aligned with
organisations active in the R&D of new biotech treatment methods.
the continuing evolution of pharma services”.
Companies on the lookout for partners to help them develop new BioPh will feature strongly in the inaugural ‘Global Sourcing and
biopharmaceutical treatments and processes will be able to access Contracting Strategies’ seminar series, launching on October 12th
more than 120 partner networking opportunities. in meeting rooms N101 and N102, close to Hall 10.
BioPh will be covered in the new pre-show seminar series
Key themes relevant for BioPh, CPhI and ICSE audiences will be
‘Global Sourcing and Contracting Strategies’, taking place on
covered in the comprehensive programme. Pre-show seminars will
October 12th (see below). In addition to BioPh exhibitors, around
take place from around 12-6pm.
300 CPhI exhibitors supplying bio-ingredients will also make up the
The multi-track format will offer a selection of bookable 30-minute
BioPh trail.
mini-seminars on critical industry issues. Each track will link a series
BioPh builds on the success of the Biotech Zone, introduced at our
of topical seminars, delivered by dedicated industry speakers, with
Milan show in 2007. It aims to provide a fresh focus on biotech as
Q&A sessions and networking/refreshment breaks.
the innovation driver for the whole pharmaceutical community.
BioPh track themes will be:
The BioPh package will refl ect both big pharma’s growing
• Biomanufacturing (successful outsourcing);
38
partnerships with biotech and the increase in outsourcing to
• Financing (credit crunch implications and alternative fi nancing);
contract service providers by both the pharma and biotech sectors.
• Biosimilars (regulatory guidelines and the potential impact of US
Such activities range from product development and clinical trials, to
healthcare policy developments); and
manufacturing and market supply logistics.
• In-& out-licensing: trends and developments.
“BioPh will provide a natural and timely focus for the convergence
Full information and speaker details will be available at
of pharma and biotech across the global healthcare space. This has
bioph-online.com or by email request to: bioph@ubm.com.
been accelerated by the exceptional market and business conditions
of recent quarters,” explains BioPh event director Haf Cennydd. The full programme will also appear in the electronic Pre-Show
Daily, published in September.
“CPhI Worldwide is already positioned as an unrivalled, proven
networking platform for ingredients and production interests, and Madrid is, of course, no stranger to CPhI-connected debuts. In
broader than many pure bio platforms. BioPh will add value at the 2005, the Feria de Madrid hosted the launch of the now well-
very centre of the pharma production sector’s leading global event.” established P-MEC pharma machinery and equipment exhibition.
List of BioPh Exhibitors (as of 10th July)
Amega Biotech Argentina 8BIO07 MetGen Finland 8BIO23
BAG Healthcare Germany 8BIO26 Newlab Bioquality Germany 8BIO20
Biovian Finland 8BIO49 Nova Laboratories UK 8BIO25
CIT France 8BIO48 OctoPlus Netherlands 8BIO47
Créapharm/MP5 France 8BIO22 Putman Media US tbc
Five Pharma Scienticfi c Rep. of Ireland 8BIO42 SCM Pharma UK 8BIO18
Glycotope Germany 8BIO45 Shandon Clinical Trials Rep. of Ireland 8BIO42
Harlan Laboratories Switzerland 8BIO05 Statens Serum Institute Denmark 8BIO46
Interpress Switzerland tbc TCP Services France 8BIO36
Intertek ASG UK 8BIO40 Texcell France 8BIO22
Lyofal France 8BIO36 TransGenRx US 8BIO38
Merck KGaA Germany 8BIO16 YMC Europe Germany 8BIO11
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44